MedTrace Logo

Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?

NCT01705171 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2018-12-17

No results posted yet for this study

Summary

In this study we will investigate the expression of the fructose transport protein GLUT5 in the small intestine in patients with functional GI disoders and fructose intolerance compared to matched healthy controls.

Conditions

  • Irritable Bowel Syndrome
  • Fructose Intolerance

Sponsors & Collaborators

  • Brain-Gut Research Group

    lead OTHER

Principal Investigators

  • C Wilder-Smith, MD · Brain-Gut Research Group

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-05-31
Completion
2013-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705171 on ClinicalTrials.gov